Skip Navigation


JAC Advance Access originally published online on May 12, 2006
Journal of Antimicrobial Chemotherapy 2006 58(2):478; doi:10.1093/jac/dkl193
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
58/2/478    most recent
dkl193v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rolston, K. V. I.
Right arrow Articles by Bodey, G. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rolston, K. V. I.
Right arrow Articles by Bodey, G. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Correspondence

Comment on: Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials

Kenneth V. I. Rolston* and Gerald P. Bodey

Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M.D. Anderson Cancer Center Houston, TX, USA

*Corresponding author. Tel: +1-713-792-6830; Fax: +1-713-745-6839; E-mail: krolston@mdanderson.org

Keywords: febrile neutropenia , monotherapy , ceftazidime

The first 10% of the full text of this article appears below.

Sir,

The meta-analysis conducted by Paul et al.1 regarding empirical antibiotic monotherapy for febrile neutropenia illustrates the dangers of relying on such analyses to make therapeutic recommendations in an area characterized by rapid changes. We are particularly concerned with the conclusions that ceftazidime is suitable . . . [Full Text of this Article]

Transparency declarations


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
M. Paul, A. Fraser, and L. Leibovici
Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials: authors' response
J. Antimicrob. Chemother., August 1, 2006; 58(2): 479 - 480.
[Full Text] [PDF]